James Mcnulty - CHIEF FINANCIAL OFFICER, 10%+ Owner at Inhibitor Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CHIEF FINANCIAL OFFICER, 10%+ Owner
Stock Symbol
INTI on OTC
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by James Mcnulty since 11/21/2023

Holdings reported by James Mcnulty for Inhibitor Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 26.1M May 5, 2023 Indirect
Common Stock 946K May 5, 2023 Direct
Stock Option 100K Mar 16, 2024 Direct Common Stock

Transactions reported by James Mcnulty for Inhibitor Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.